サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1455224

薬剤溶出バルーンカテーテルの世界市場レポート 2024年

Drug Eluting Balloons Catheters Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
薬剤溶出バルーンカテーテルの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

薬剤溶出バルーンカテーテルの市場規模は、今後数年間で急速に成長すると予想されています。 2028年には13.2%の年間複合成長率（CAGR）で23億5,000万米ドルに成長すると予想されます。予測期間で予想される成長は、呼吸器疾患の継続的な増加、高齢者人口の拡大、呼吸器の健康に関する意識と教育の高まり、新興国での市場拡大、カスタマイズされた製剤の開発、規制のサポートとコンプライアンス、および吸入器業界におけるパッケージングとデザインの革新。予測期間中に予想される主な動向には、スマート吸入器と接続性の出現、呼吸作動吸入器への移行、小児および高齢者患者のニーズを満たすことへの注力、生物製剤送達の進歩、環境に優しい吸入器設計の開発などが含まれます。

末梢血管疾患および心血管疾患の有病率の予想される増加は、将来の薬剤溶出バルーンカテーテル市場の成長を促進すると予想されます。心血管疾患（CVD）には心臓や循環器系に影響を与えるさまざまな症状が含まれますが、末梢動脈疾患（PAD）には特に腕や脚への血流が減少する動脈の狭窄が関係します。冠状動脈疾患（CAD）の治療法である薬剤溶出バルーンカテーテルは、抗増殖物質でコーティングされたセミコンプライアント血管形成バルーンを採用しており、血管に入ると抗再狭窄効果をもたらします。たとえば、2023年4月、英国心臓財団は、英国における冠状動脈性心疾患による死亡者数が2020年の6万4,170人から2021年には6万5,579人に増加したと報告しました。さらに、HMP世界は、米国の末梢動脈疾患有病者数が2030年までに2,380万人に達すると予測しました。したがって、末梢血管疾患および心血管疾患の有病率の増加が、薬剤溶出バルーンカテーテル市場の原動力となっています。

低侵襲処置に対する需要の高まりにより、薬剤溶出バルーンカテーテル市場の成長がさらに促進されると予想されます。低侵襲手術には小さな切開を伴う外科技術が含まれ、治癒時間が短縮され、痛みが軽減され、感染リスクが低くなります。薬剤溶出バルーンは、これらの処置において極めて重要であり、薬剤を治療領域に直接送達して再狭窄を防ぎ、血管介入の有効性を高める。たとえば、Intuitive Surgical Inc.は、Vinci外科システムを使用した外科手術件数が2021年の1,594,000件から2022年には1,875,000件へと18%増加したと報告しました。さらに、米国形成外科医協会は、米国における美容低侵襲手術件数が23,672,269件に増加したことを指摘しました。したがって、低侵襲処置に対する需要の高まりが、薬剤溶出バルーンカテーテル市場の成長を推進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の薬剤溶出バルーンカテーテル市場促進要因と制約
    • 市場の促進要因
    • 市場の抑制要因
  • 世界の薬剤溶出バルーンカテーテル市場規模実績と成長、2018年～2023年
  • 世界の薬剤溶出バルーンカテーテル市場規模と成長予測、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の薬剤溶出バルーンカテーテル市場、製品別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 冠動脈疾患用薬剤溶出バルーンカテーテル
  • 末梢血管疾患用薬剤溶出バルーンカテーテル
  • 世界の薬剤溶出バルーンカテーテル市場、薬剤別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • パクリタキセル
  • シロリムス
  • その他の薬物
  • 世界の薬剤溶出バルーンカテーテル市場、原材料別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • ナイロン
  • ポリウレタン
  • その他の原材料
  • 世界の薬剤溶出バルーンカテーテル市場、エンドユーザー別のセグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 病院と診療所
  • 外来手術センター
  • カテーテル検査研究所

第7章 地域および国の分析

  • 世界の薬剤溶出バルーンカテーテル市場、地域別、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 世界の薬剤溶出バルーンカテーテル市場、国別、実績および予測、2018年～2023年、2023年～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 薬物溶出バルーンカテーテル市場の競合情勢
  • 薬物溶出バルーンカテーテル市場企業プロファイル
    • Abbott Laboratories
    • Medtronic PLC
    • Becton Dickinson and Company
    • Koninklijke Philips NV
    • Boston Scientific Corporation

第31章 その他の主要および革新的な企業

  • B Braun Melsungen Aktiengesellschaft
  • Terumo Corporation
  • Cook Medical LLC
  • Lepu Medical Technology Co. Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • BIOTRONIK SE &Co. KG
  • Acotec Scientific Co. Ltd.
  • Cordis Corporation
  • Biosensors International Group Ltd.
  • Zylox-Tonbridge Medical Technology Co. Ltd.
  • Mermaid Medical AS
  • Hexacath Limited
  • Zhejiang Barty Medical Technology Co. Ltd.
  • Cardionovum GmbH

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r16225

A drug-eluting balloon catheter is a medical device utilized in the treatment of coronary artery disease through percutaneous coronary intervention (PCI). It is a semi-compliant angioplasty balloon that is coated with an anti-proliferative drug. During inflation, the drug is released into the vessel wall, aiming to prevent restenosis and reduce the risk of late thrombosis without the need for implanting a permanent foreign object.

The main types of drug-eluting balloon catheters include those designed for coronary artery disease and peripheral vascular disease. Coronary artery disease drug-eluting balloon catheters deliver antiproliferative drugs directly to the vessel wall using a lipophilic matrix, eliminating the need for a permanent structure such as a metal prosthesis or persistent polymer. Various drugs such as paclitaxel and sirolimus are used, and the catheters are made from raw materials such as nylon, polyurethane, and others. They find applications in hospitals, clinics, ambulatory surgical centers, and catheterization laboratories.

The drug eluting balloons catherers market research report is one of a series of new reports from The Business Research Company that provides drug eluting balloons catherers market statistics, including drug eluting balloons catherers industry global market size, regional shares, competitors with a drug eluting balloons catherers market share, detailed drug eluting balloons catherers market segments, market trends and opportunities, and any further data you may need to thrive in the drug eluting balloons catherers industry. This drug eluting balloons catherers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug eluting balloons catheters market size has grown rapidly in recent years. It will grow from $1.23 billion in 2023 to $1.43 billion in 2024 at a compound annual growth rate (CAGR) of 16.3%. The growth observed in the historical period can be attributed to factors such as the increasing prevalence of respiratory disorders, the advantages offered over traditional inhalers, patient preferences for dry powder inhalers (DPIs), government initiatives for respiratory health, strategic collaborations and partnerships in the healthcare sector, advancements in drug formulations, and the rising geriatric population.

The drug eluting balloons catheters market size is expected to see rapid growth in the next few years. It will grow to $2.35 billion in 2028 at a compound annual growth rate (CAGR) of 13.2%. The anticipated growth in the forecast period can be attributed to the ongoing increase in respiratory disorders, the expanding geriatric population, rising awareness and education regarding respiratory health, market expansion in emerging economies, the development of customized drug formulations, regulatory support and compliance, and innovations in packaging and design within the inhaler industry. Major trends expected in the forecast period include the emergence of smart inhalers and connectivity, a shift towards breath-actuated inhalers, a focus on meeting the needs of pediatric and geriatric patients, advancements in biologics delivery, and the development of environmentally friendly inhaler designs.

The anticipated rise in the prevalence of peripheral and cardiovascular diseases is set to drive the growth of the drug-eluting balloon catheter market in the future. Cardiovascular diseases (CVDs) encompass a range of conditions affecting the heart and circulatory system, while peripheral artery disease (PAD) specifically involves narrowed arteries reducing blood flow to the arms or legs. Drug-eluting balloon catheters, a treatment for coronary artery disease (CAD), employ a semi-compliant angioplasty balloon coated with an anti-proliferative substance, providing an anti-restenotic effect upon entering the vessel. For example, in April 2023, the British Heart Foundation reported a rise in coronary heart disease deaths in the UK from 64,170 in 2020 to 65,579 in 2021. Additionally, HMP Global projected that peripheral arterial disease prevalence in the US would reach 23.8 million by 2030, up from 21.0 million in 2020. Hence, the growing prevalence of peripheral and cardiovascular diseases is a driving force behind the drug-eluting balloon catheter market.

The increasing demand for minimally invasive procedures is expected to further propel the growth of the drug-eluting balloon catheter market. Minimally invasive procedures involve surgical techniques with small incisions, resulting in reduced healing time, less pain, and lower infection risks. Drug-eluting balloons are crucial in these procedures, delivering medication directly to the treatment area to prevent restenosis and enhance the effectiveness of vascular interventions. For instance, Intuitive Surgical Inc. reported an 18% increase in surgical procedures using Vinci surgical systems from 1,594,000 in 2021 to 1,875,000 in 2022. Additionally, the American Society of Plastic Surgeons noted a rise in cosmetic minimally invasive procedures in the US to 23,672,269 in 2022. Therefore, the increasing demand for minimally invasive procedures is driving the growth of the drug-eluting balloon catheter market.

The negative impact of adverse effects associated with the treatment hindered the growth of the drug-eluting balloon catheter market during the historic period. While drug-eluting balloons present a promising treatment for coronary artery disease, careful consideration is necessary due to potential side effects. Medtronic PLC highlighted potential complications, including balloon rupture, detachment of components, failure to perform as intended, and failure to cross the lesion during peripheral balloon catheterization. Hence, adverse effects can negatively impact the growth of the drug-eluting balloon catheter market.

Major companies in the drug-eluting balloon catheter market are intensifying their focus on developing next-generation products with advanced technologies to gain a competitive edge. For instance, Medtronic PLC launched Prevail DCB in Europe in July 2021, the latest-generation drug-coated balloon catheter for treating coronary artery disease. Integrating paclitaxel, a quickly absorbed drug, and PowerTrac technology from Medtronic Resolute Onyx DES delivery system, Prevail DCB offers superior deliverability and pushing power in PCI procedures.

In June 2023, Translumina Therapeutics Company acquired Blue Medical Devices BV for an undisclosed amount. This strategic acquisition aimed to integrate Blue Medical's unique drug application technology into Translumina's product lines, expanding offerings in neurovascular and peripheral interventions and enhancing drug coating capabilities. Blue Medical Devices BV is a Netherlands-based medical device company specializing in producing drug-eluting balloon catheters.

Major companies operating in the drug eluting balloons catheters market report are Abbott Laboratories, Medtronic PLC, Becton Dickinson and Company, Koninklijke Philips NV, Boston Scientific Corporation, B Braun Melsungen Aktiengesellschaft, Terumo Corporation, Cook Medical LLC, Lepu Medical Technology Co. Ltd., Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, BIOTRONIK SE & Co. KG, Acotec Scientific Co. Ltd., Cordis Corporation, Biosensors International Group Ltd., Zylox-Tonbridge Medical Technology Co. Ltd., Mermaid Medical AS, Hexacath Limited, Zhejiang Barty Medical Technology Co. Ltd., Cardionovum GmbH, Nano Therapeutics Pvt. Ltd., Tokai Medical Products Inc., Opto Circuits Limited, Acrostak (Schweiz) AG, Machine Solutions Inc., Concept Medical Inc., Aachen Resonance GmbH, AR Baltic Medical UAB.

North America was the largest region in the drug eluting balloons catheters market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting balloons catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug-eluting balloon catheter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drug-eluting balloon catheter market consists of sales of everolimus and stellarex. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Eluting Balloons Catheters Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug eluting balloons catheters market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug eluting balloons catheters ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug eluting balloons catheters market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Coronary Artery Disease Drug-Eluting Balloon Catheters; Peripheral Vascular Disease Drug-Eluting Balloon Catheters
  • 2) By Drug: Paclitaxel; Sirolimus; Other Drugs
  • 3) By Raw Material: Nylon; Polyurethane; Other Raw Materials
  • 4) By End-User: Hospitals And Clinics; Ambulatory Surgical Centers; Catheterization Laboratories
  • Companies Mentioned: Abbott Laboratories; Medtronic PLC; Becton Dickinson and Company; Koninklijke Philips NV; Boston Scientific Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug Eluting Balloons Catheters Market Characteristics

3. Drug Eluting Balloons Catheters Market Trends And Strategies

4. Drug Eluting Balloons Catheters Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Drug Eluting Balloons Catheters Market Size and Growth

  • 5.1. Global Drug Eluting Balloons Catheters Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Drug Eluting Balloons Catheters Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Drug Eluting Balloons Catheters Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Drug Eluting Balloons Catheters Market Segmentation

  • 6.1. Global Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Coronary Artery Disease Drug-Eluting Balloon Catheters
  • Peripheral Vascular Disease Drug-Eluting Balloon Catheters
  • 6.2. Global Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Paclitaxel
  • Sirolimus
  • Other Drugs
  • 6.3. Global Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Nylon
  • Polyurethane
  • Other Raw Materials
  • 6.4. Global Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Clinics
  • Ambulatory Surgical Centers
  • Catheterization Laboratories

7. Drug Eluting Balloons Catheters Market Regional And Country Analysis

  • 7.1. Global Drug Eluting Balloons Catheters Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Drug Eluting Balloons Catheters Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Drug Eluting Balloons Catheters Market

  • 8.1. Asia-Pacific Drug Eluting Balloons Catheters Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Drug Eluting Balloons Catheters Market

  • 9.1. China Drug Eluting Balloons Catheters Market Overview
  • 9.2. China Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Drug Eluting Balloons Catheters Market

  • 10.1. India Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Drug Eluting Balloons Catheters Market

  • 11.1. Japan Drug Eluting Balloons Catheters Market Overview
  • 11.2. Japan Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Drug Eluting Balloons Catheters Market

  • 12.1. Australia Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Drug Eluting Balloons Catheters Market

  • 13.1. Indonesia Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Drug Eluting Balloons Catheters Market

  • 14.1. South Korea Drug Eluting Balloons Catheters Market Overview
  • 14.2. South Korea Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Drug Eluting Balloons Catheters Market

  • 15.1. Western Europe Drug Eluting Balloons Catheters Market Overview
  • 15.2. Western Europe Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Drug Eluting Balloons Catheters Market

  • 16.1. UK Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Drug Eluting Balloons Catheters Market

  • 17.1. Germany Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Drug Eluting Balloons Catheters Market

  • 18.1. France Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Drug Eluting Balloons Catheters Market

  • 19.1. Italy Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Drug Eluting Balloons Catheters Market

  • 20.1. Spain Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Drug Eluting Balloons Catheters Market

  • 21.1. Eastern Europe Drug Eluting Balloons Catheters Market Overview
  • 21.2. Eastern Europe Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Drug Eluting Balloons Catheters Market

  • 22.1. Russia Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Drug Eluting Balloons Catheters Market

  • 23.1. North America Drug Eluting Balloons Catheters Market Overview
  • 23.2. North America Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Drug Eluting Balloons Catheters Market

  • 24.1. USA Drug Eluting Balloons Catheters Market Overview
  • 24.2. USA Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Drug Eluting Balloons Catheters Market

  • 25.1. Canada Drug Eluting Balloons Catheters Market Overview
  • 25.2. Canada Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Drug Eluting Balloons Catheters Market

  • 26.1. South America Drug Eluting Balloons Catheters Market Overview
  • 26.2. South America Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Drug Eluting Balloons Catheters Market

  • 27.1. Brazil Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Drug Eluting Balloons Catheters Market

  • 28.1. Middle East Drug Eluting Balloons Catheters Market Overview
  • 28.2. Middle East Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Drug Eluting Balloons Catheters Market

  • 29.1. Africa Drug Eluting Balloons Catheters Market Overview
  • 29.2. Africa Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Drug Eluting Balloons Catheters Market Competitive Landscape And Company Profiles

  • 30.1. Drug Eluting Balloons Catheters Market Competitive Landscape
  • 30.2. Drug Eluting Balloons Catheters Market Company Profiles
    • 30.2.1. Abbott Laboratories
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Medtronic PLC
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Becton Dickinson and Company
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Koninklijke Philips NV
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Boston Scientific Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Drug Eluting Balloons Catheters Market Other Major And Innovative Companies

  • 31.1. B Braun Melsungen Aktiengesellschaft
  • 31.2. Terumo Corporation
  • 31.3. Cook Medical LLC
  • 31.4. Lepu Medical Technology Co. Ltd.
  • 31.5. Meril Life Sciences Pvt. Ltd.
  • 31.6. MicroPort Scientific Corporation
  • 31.7. BIOTRONIK SE & Co. KG
  • 31.8. Acotec Scientific Co. Ltd.
  • 31.9. Cordis Corporation
  • 31.10. Biosensors International Group Ltd.
  • 31.11. Zylox-Tonbridge Medical Technology Co. Ltd.
  • 31.12. Mermaid Medical AS
  • 31.13. Hexacath Limited
  • 31.14. Zhejiang Barty Medical Technology Co. Ltd.
  • 31.15. Cardionovum GmbH

32. Global Drug Eluting Balloons Catheters Market Competitive Benchmarking

33. Global Drug Eluting Balloons Catheters Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Drug Eluting Balloons Catheters Market

35. Drug Eluting Balloons Catheters Market Future Outlook and Potential Analysis

  • 35.1 Drug Eluting Balloons Catheters Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Drug Eluting Balloons Catheters Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Drug Eluting Balloons Catheters Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer